Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome Study to Evaluate the Role of Klaricid XL (Clarithromycin Modified Release) in the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB) and Its Impact on Quality of Life Measured by St. George's Respiratory Questionnaire (SGRQ)

NCT01354938 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01354938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01354938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome Study to Evaluate the Role of Klaricid XL (Clarithromycin Modified Release) in the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB) and Its Impact on Quality of Life Measured by St. George's Respiratory Questionnaire (SGRQ)
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
January 31, 2012
Enrollment
220 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

bronchitis